Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results - HIMS investor relations
Article excerpt
Highlighted: the sentence this signal was extracted from
Revenue of approximately $890 million, up 49% year-over-year in Q3 2026 Subscribers grew to nearly 2.8 million, up 13% year-over-year in Q3 2026 Tightens full year 2026 revenue guidance to a range of $3.13 billion to $3.15 billion and reduces Adjusted EBITDA guidance to a range of $257 million to $277 million SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the third quarter ended September 30, 2026. "In healthcare, whoever owns the customer relationship wins, and that's exactly what we're building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them," said Andrew Dudum, co-founder and CEO. "Everything we're doing, from expanding the treatments and specialties we make available, to rolling out an AI-native experience to support every customer's care, informed by leading minds in health and science, is designed to meet that higher bar. The platform people can rely on for their health every day, in every category, and every market, is the platform that will transform the industry. We believe we are building that platform." "In the third quarter, we continued to apply what we've learned to make deliberate strategic decisions to position Hims & Hers for durable, multi-year growth," said Yemi...
Keep reading with a free account
The rest of this article, and every signal for Hims & Hers, is in your free account.